Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study.

Courtney Lawhn-HeathSue S YomChienying LiuJavier E Villanueva-MeyerMaya AslamRaven SmithManpreet NarwalRoxanna JuarezSpencer C BehrMiguel Hernandez PampaloniJason W ChanChristine M GlastonburyThomas A HopeRobert Richard Flavell

Published in: EJNMMI research (2020)

[68Ga]Ga-PSMA-11 PET demonstrated lower detection rate when compared to 2-[18F]FDG PET for thyroid cancer lesion visualization. Thyroid cancer subtype alone may not be sufficient to predict PSMA uptake, and radiotracer uptake may vary between patients and even within patients.

Keyphrases

pet ct
pet imaging
positron emission tomography
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
prostate cancer
prognostic factors
peritoneal dialysis
high resolution
real time pcr